GlassScriptPhysician profile
Janice Joo
NPI 1639532187
$7,364.60
in general payments reported to CMS, 2019-2025
52 companies · $2,585 in 2025
The $2,585 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2022: $584 · 2023: $2,072 · 2024: $2,005 · 2025: $2,585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,646 · Education: $16.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,646.47 |
| Education | $16.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $842.95 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $676.38 | 2019-2025 | |
| Biogen, INC. | $590.23 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Pfizer INC. | $427.24 | 2023-2025 | |
| Ucb, INC. | $367.37 | 2022-2025 | Briviact, Fintepla, Rystiggo |
| Sk Life Science, INC. | $366.83 | 2023-2025 | Xcopri |
| Lundbeck LLC | $334.07 | 2022-2025 | Vyepti |
| Lilly USA, LLC | $303.05 | 2023-2025 | Kisunla, Emgality, Amyvid |
| Neurocrine Biosciences, INC. | $249.54 | 2022-2025 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $215.28 | 2022-2025 | Ultomiris |
| Amneal Pharmaceuticals LLC | $200.04 | 2022-2025 | Crexont, Rytary |
| Merz Pharmaceuticals, LLC | $198.71 | 2022-2024 | Xeomin |
| Teva Pharmaceuticals USA, INC. | $167.68 | 2023-2025 | Austedo Xr, Austedo Xr |
| Neurelis, INC. | $160.44 | 2024-2025 | Valtoco |
| Eisai INC. | $156.13 | 2024-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $146.42 | 2023-2025 | Mavenclad |
| Mallinckrodt Hospital Products INC. | $143.97 | 2024-2025 | Acthar |
| Acadia Pharmaceuticals INC | $137.37 | 2025 | Nuplazid, Daybue |
| Otsuka America Pharmaceutical, INC. | $119.80 | 2023-2024 | Rexulti, Nuedexta |
| Ipsen Biopharmaceuticals, INC | $115.20 | 2023-2025 | Dysport |
| Takeda Pharmaceuticals U.S.A., INC. | $110.21 | 2022-2023 | Gammagard |
| Celgene Corporation | $103.24 | 2024-2025 | Zeposia |
| Amgen INC. | $90.93 | 2022-2024 | Aimovig, Uplizna |
| Tanabe Pharma America, INC. | $73.00 | 2024 | |
| Genentech USA, INC. | $70.75 | 2023-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| C2n Diagnostics, LLC | $66.54 | 2025 | Precivityad2 |
| Corium, LLC | $61.20 | 2022-2023 | Adlarity |
| Axsome Therapeutics, INC. | $58.94 | 2025 | Symbravo |
| Grifols USA, LLC | $56.27 | 2024-2025 | Gamunex-C |
| Genzyme Corporation | $52.16 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $51.77 | 2022 | |
| Horizon Therapeutics Plc | $51.10 | 2022-2023 | Uplizna |
| Jazz Pharmaceuticals INC. | $50.51 | 2024-2025 | |
| Tg Therapeutics, INC. | $47.83 | 2025 | |
| Microtransponder, INC. | $46.06 | 2025 | |
| Azurity Pharmaceuticals, INC. | $44.51 | 2023-2025 | Horizant |
| Xeris Pharmaceuticals, INC. | $38.43 | 2025 | Keveyis |
| Kyowa Kirin, INC. | $36.60 | 2023-2024 | Nourianz |
| Allergan, INC. | $35.49 | 2022 | |
| Electromed, INC. | $33.44 | 2024 | Smartvest |
| Argenx US, INC. | $30.75 | 2025 | Vyvgart Hytrulo |
| Janssen Biotech, INC. | $28.22 | 2025 | |
| Boston Scientific Corporation | $25.67 | 2025 | Watchman Flx |
| Ge Healthcare | $24.13 | 2025 | |
| Livanova USA, INC. | $22.79 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Sumitomo Pharma America, INC. | $21.98 | 2023 | Aptiom |
| Octapharma USA, INC. | $21.65 | 2023 | Panzyga |
| Banner Life Sciences, LLC | $21.36 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $20.89 | 2023 | Fycompa |
| Ani Pharmaceuticals, INC. | $18.20 | 2025 | Purified Cortrophin Gel |
| Mdd US Operations, LLC | $17.41 | 2025 | |
| Scilex Pharmaceuticals INC. | $13.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Joo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.